Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).Susan F. Slovin, Eric Ostertag, Gerald S. Falchook et al.|Journal of Clinical Oncology|2022Cited by 51